Skip to contentC
Catheter Precision, Inc.
C
VJETCatheter Precision, Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$149.00K$149.00Kderived+16.4% vs Q4 2023 Net Income-$5.63M-$5.63MderivedN/M vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Catheter Precision, Inc. · CIK 1716621 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$138,000+14.0% Operating Incomederived-$3,051,000N/M Operating Cash Flowderived-$2,864,000N/M Free Cash Flowderived-$2,864,000N/M Margins · derivedGross margin92.6%−1.9 pt vs Q4 2023
Operating margin-2047.7%−18.7 pt vs Q4 2023
Net margin-3777.2%−3254.5 pt vs Q4 2023
ended Dec 31, 2024 · filed Mar 31, 2025 · 90 d after period end